NOV 19, 2019 3:29 PM PST

Psychedelic DMT Creates Vivid Waking Dream State in Brain

WRITTEN BY: Annie Lennon

In a new study, scientists at Imperial College London investigated how powerful psychedelic dimethyltryptamine (DMT) alters the brain’s electrical activity. One of the main psychoactive substances in ayahuasca, a psychedelic brew traditionally consumed in the Amazon, the researchers found that the drug stimulates the brain to reach a state of “dreaming while awake”. 

For the study, the researchers gave 13 participants an intravenous infusion of DMT. Fitted with caps containing electrodes, they then measured their brain’s electrical activity before, during and after the hit- over a total of around 10 minutes (Georgiou: 2019). 

Analyzing the results, the researchers found that DMT significantly altered the brain’s electrical activity. In particular, they found a significant reduction in alpha waves- something we produce a lot of while awake. Meanwhile, they found a short-lived increase in theta waves, typically produced while dreaming. Alongside these changes, they also found that brain activity became more chaotic and less predictable- contrary to typical reactions to reduced consciousness, such as while sleeping. 

The lead author of the study, Christopher Timmermann, from the Centre for Psychedelic Research said, “The changes in brain activity that accompany DMT are slightly different from what we see with other psychedelics such as psilocybin or LSD, where we see mainly only reductions in brainwaves.”

He continued, “Here we saw an emergent rhythm that was present during the most intense part of the experience, suggesting an emerging order amidst the otherwise chaotic patterns of brain activity. From the altered brainwaves and participants' reports, it's clear these people are completely immersed in their experience - it's like daydreaming only far more vivid and immersive, it's like dreaming but with your eyes open (Imperial College London: 2019).”

Although it is so far not clear whether DMT has any potential in a clinical setting, the researchers hope to conduct further research on its properties, first and foremost by extending the DMT experience to collect more data. According to Dr. Robin Carhard-Harris, head of the Centre of Psychedelic Research, “Our sense it that research with DMT may yield important insights into the relationship between brain activity and consciousness, and this small study is a first step along that road (ibid.)."

 

Sources

 

Georgiou, Aristos: News Week 

Imperial College London

 

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
The unlikely pain killer
Pain can be anything a sunburn, a toothache, or a leg injury to name a few. The relievers that target our pain come in many colors—one being morphine...
JAN 25, 2020
Cannabis Sciences
JAN 25, 2020
Is Cannabis Helping America Sleep?
Researchers find cannabis is being used as a sleep-aid in Colorado. Many Americans struggle with sleep disturbances -- some estimates put the percentage at...
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
Loading Comments...